SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-005188
Filing Date
2023-03-31
Accepted
2023-03-31 07:10:24
Documents
14
Period of Report
2023-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpth-20230331x8k.htm   iXBRL 8-K 38803
2 EX-99.1 bpth-20230331xex99d1.htm EX-99.1 22767
3 GRAPHIC bpth-20230331xex99d1001.jpg GRAPHIC 8289
  Complete submission text file 0001558370-23-005188.txt   198959

Data Files

Seq Description Document Type Size
4 EX-101.SCH bpth-20230331.xsd EX-101.SCH 3155
5 EX-101.LAB bpth-20230331_lab.xml EX-101.LAB 15928
6 EX-101.PRE bpth-20230331_pre.xml EX-101.PRE 10128
8 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20230331x8k_htm.xml XML 4867
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 23783175
SIC: 2834 Pharmaceutical Preparations